Stuttgart
28.09.26 | 19:02
0,228 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,226 | 0,236 | 19:24 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:26 | Senzime Strengthens Financing to Support Strategic OEM Expansion and Path to Profitability | 225 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 28, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has strengthened its financing structure through a new SEK 35 million non-dilutive... ► Artikel lesen | |
| 15:00 | Senzime AB: Senzime strengthens financing to support strategic OEM expansion and path to profitability | 100 | GlobeNewswire (Europe) | Uppsala, Sweden - Senzime AB today announced that it has strengthened its financing structure through a new SEK 35 million non-dilutive credit facility with a group of institutional investors, including... ► Artikel lesen | |
| Do | Senzime Secures Additional Major US Hospital Network Contract, Expanding Adoption of its Next-generation Neuromuscular Monitoring Technology | 309 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / September 24, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another contract with a leading multi-hospital academic health system based... ► Artikel lesen | |
| 05.08. | Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed | 417 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / August 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a leader in precision-based perioperative monitoring solutions, today announced that the U.S. Department of... ► Artikel lesen | |
| 16.07. | Senzime AB (publ) reports Q2 results | 1 | Seeking Alpha | ||
| 16.07. | Senzime: Interim Report Q2 2026: Strong Sensor Sales and Improved Margins, Despite Continued U.S. Monitor Market Headwinds | 578 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 16, 2026 / Senzime AB's (publ) (STO:SEZI)(OTCQX:SNZZF) interim report for April - June (Q2) 2026 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| SENZIME Aktie jetzt für 0€ handeln | |||||
| 15.07. | Senzime and Philips Medical Systems Enter Development and Commercialization Partnership | 500 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 15, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB announced today that it has entered into a long-term agreement with Philips Electronics Nederland, B.V. through... ► Artikel lesen | |
| 13.07. | Invitation to Presentations of Senzime's Second Quarter 2026 Report | 350 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 13, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to presentations of the second quarter report for 2026 on July 16. The report will... ► Artikel lesen | |
| 29.06. | Senzime's TetraGraph System Receives ANVISA Regulatory Approval in Brazil | 374 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) announced today that the TetraGraph system has received approval from the Brazilian Health Regulatory Agency (ANVISA)... ► Artikel lesen | |
| 05.06. | Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026 | 352 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 5, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the launch of TetraAnalytics, a new data analytics... ► Artikel lesen | |
| 03.06. | Senzime Strengthens Position in Pediatric Anesthesia by Securing Another Hospital Contract and Highlighting Positive Outcome Data | 378 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 3, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) announced today advancements within pediatric anesthesia, securing another top ranked pediatric hospital contract. The... ► Artikel lesen | |
| 01.06. | Senzime Advances Sustainable Anesthesia Monitoring with Launch of New EMG Sensor | 324 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 1, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced the launch of its latest TetraSens EMG sensor for use with the TetraGraph Train-of-Four monitoring system.... ► Artikel lesen | |
| 27.05. | From Science to Practice: Senzime Obtains FDA 510(k) Clearance for Enhanced TetraGraph System | 581 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph neuromuscular monitoring system has received an additional FDA Class II... ► Artikel lesen | |
| 19.05. | Bulletin From Annual General Meeting in Senzime AB | 417 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 19, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2026 at... ► Artikel lesen | |
| 29.04. | Senzime Strengthens U.S. Operations with New Leadership Appointments | 429 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced new appointments to its Global Executive Leadership Team, including the recruitment of a... ► Artikel lesen | |
| 24.04. | Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US | 212 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that the TetraGraph System has secured inclusion in agreements with Vizient, Premier, and... ► Artikel lesen | |
| 24.04. | Senzime Publishes Annual and Sustainability Report for 2025 | 199 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report for 2025 is published and available... ► Artikel lesen | |
| 22.04. | Senzime AB (publ) reports Q1 results | 2 | Seeking Alpha | ||
| 22.04. | Senzime: Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on Track | 405 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 22, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2026 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 20.04. | Senzime Wins Expanded Contract Within Leading Southeastern US Hospital System | 432 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 20, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has expanded its agreements with a leading hospital system (IDN) with network in... ► Artikel lesen |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 31,440 | -1,52 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| ECKERT & ZIEGLER | 12,550 | 0,00 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| INTUITIVE SURGICAL | 365,40 | +2,83 % | 1.156 Trades im Juli: Das sind Trumps Aktien-Zocks: Millionenverkäufe bei zwei Tech-Riesen | © Foto: Julia Demaree Nikhinson - APIn Trumps Depot wurden im Juli 1.156 Transaktionen verzeichnet, darunter Verkäufe von Microsoft- und Amazon-Aktien für jeweils bis zu 25 Millionen US-Dollar sowie... ► Artikel lesen | |
| UNITEDHEALTH | 331,80 | +0,36 % | Roundhill UNH WeeklyPayTM ETF declares $0.2807 dividend | ||
| DRAEGERWERK | 124,40 | +0,49 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| GERRESHEIMER | 27,480 | -0,53 % | EQS-AFR: Gerresheimer AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Gerresheimer AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Gerresheimer AG: Vorabbekanntmachung über... ► Artikel lesen | |
| THERMO FISHER | 599,60 | +1,25 % | Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno | Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflowsSINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| TELADOC HEALTH | 5,298 | -0,79 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| ESSILORLUXOTTICA | 148,25 | +2,31 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für EssilorLuxottica von 230 auf 190 Euro gesenkt, aber die Einstufung auf "Outperform" belassen. Piral Dadhania geht in seinem... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,520 | -1,16 % | Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks | ||
| FAMICORD | 3,030 | +2,71 % | EQS-News: FamiCord AG gewinnt vielversprechenden CDMO-Neukunden mit Herstellungsvereinbarung für zulassungsrelevante Phase-II/III-Studie bei anfänglichem Volumen im niedrigen einstelligen Millionen-Euro-Bereich |
EQS-News: FamiCord AG
/ Schlagwort(e): Vertrag
FamiCord AG gewinnt vielversprechenden CDMO-Neukunden mit Herstellungsvereinbarung für zulassungsrelevante Phase-II/III-Studie bei... ► Artikel lesen | |
| M1 KLINIKEN | 20,500 | +0,50 % | M1 Kliniken-Aktie // Welch schöne Marge, welch schöner Chart | In Deutschland und nicht nur dort wird gespritzt und gefüllt. Botox- und Filler-Behandlungen (nicht nur bei Frauen) sind, was die Akzeptanz angeht, vom Frisör-Besuch kaum noch zu unterscheiden. Begonnen... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 38,345 | -0,51 % | Wells Fargo cuts Boston Scientific stock price target on cyberattack impact | ||
| DEXCOM | 76,20 | +0,26 % | DexCom, Inc.: Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care | New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1 New partnership reinforces... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 127,10 | -1,32 % | Align Technology Wins China Patent Case Against Angelalign | WASHINGTON (dpa-AFX) - Align Technology, Inc. (ALGN), said the Jinan Intermediate People's Court in China ruled in its favor in a patent infringement case against Angelalign Technology's Chinese... ► Artikel lesen |
Das Unternehmen SENZIME AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,228 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SENZIME AB finden Sie auf Wallstreet Online.